NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Back to search
Official data from USPTO
DISCOVERY LIFE SCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DISCOVERY LIFE SCIENCES
ST13
US500000098237326Class
1, 5, 39, 42
Filing
98237326
Registration
7638955
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/07/2025
Trademark type
Word
Nice classes
1, 5, 39, 42
Filing date
10/24/2023
Registration date
01/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
02/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/16/2018
First use in commerce
10/16/2018
Drawing code
4
Owner type
16
Owner location
Huntsville, AL
Examiner
MASON,JARED MICHAEL
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Discovery Life Sciences, LLC
Representatives
Discovery Life Sciences, LLC
Technical classification
Nice Classes
Class 1Class 5Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebloodstem cells for scientificlaboratory or medical researchbiological tissuea set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; cells for scientificlaboratory or medical research; Cell culture media for scientific and research use; Drug metabolism enzymes for use in toxicological research and pharmaceutical research and development; Enzymes for scientific and research purposes; Cell microsomes for scientific research use; Human and animal primary cells for scientific research; Reagents for research purposes; Reagents for scientific or medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Nutritive substances for microorganism cultures for scientific and clinical research
Class 5
Human hematology and immunology cells for medical and clinical use
Class 39
Biomedical servicesthe storage of human biological specimens for medical use
Class 42
Medical and scientific research services in the field of biological tissue; Medical and scientific research information in the field of primary cell biologystem cell biologytoxicologyresearch reagentscellscell culturethe development of research; Medical research laboratory servicescollecting and processing of human and animal hematopoietic and immunological cells; flow cytometry services being scientific and medical research; immunophenotyping services being scientific and medical research; validation of cell separation devices for clinical use being quality control testing; Laboratory scientific research in the field of primary cell biologystem cell biologytoxicologyresearch reagentscell culturethe development of research tools for same; Scientific research and development and consultation related thereto in the field of primary cell biologystem cell biologytoxicologyresearch reagentscellscell culturethe development of research tools for same; Fee-for-service commercial nonclinical sequencing of human genetic material for scientific and medical research purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2024
PUBO
PUBLISHED FOR OPPOSITION
11/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/07/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/28/2024
GNFR
FINAL REFUSAL E-MAILED
08/28/2024
CNFR
FINAL REFUSAL WRITTEN
08/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2024
GNRT
NON-FINAL ACTION E-MAILED
05/10/2024
CNRT
NON-FINAL ACTION WRITTEN
05/10/2024
DOCK
ASSIGNED TO EXAMINER
05/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2023
NWAP
NEW APPLICATION ENTERED
10/27/2023
Continuous trademark protection
Get notified about every new filing that threatens DISCOVERY LIFE SCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.